Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Novartis to sponsor Special Winter World Olympic Games
bring together athletes with cognitive disabilities to compete in elite winter sports such as skiing.
Read more
Promotion of biologics under fire from FDA
The recent FDA letters to four biologics companies signal a continued rise in enforcement activity.
Lilly and Insilico strike historic $2.75bn AI alliance
The collaboration marks one of the largest generative AI-driven partnerships in the pharmaceutical industry to date.
Gesynta’s endometriosis candidate enters phase 2
The study moves the non-hormonal endometriosis candidate into mid-stage testing in a field ripe for new options.
Takeda unveils restructure to fuel late-stage pipeline
The company has announced a multi-year initiative aimed at delivering billions of annualised gross savings by 2028.
UCB selects Georgia for new $2bn manufacturing hub
The company has selected a site for its new plant to meet what it describes as a “growing demand” for its biologics pipeline.
AbbVie to sponsor leading US baseball league
This collaboration marks the first of its kind for AbbVie and signals a massive national expansion of its ‘Striking Out Cancer’ initiative.
ABPI calls for NHS data use to boost trial recruitment
The NHS is sitting on a gold mine of patient data that could, in the ABPI’s view, help rescue the UK’s faltering clinical trials sector.
FDA backs shift to alternatives to animal testing
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing.
Loading posts...
« Previous
1
2
3
4
5
6
…
49
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View